Swiss-controlled private healthcare operator Affidea, which specialises in high-performance medical imaging and cancer treatment in 14 countries at its 179 centres across Europe, has bought 100% of the shares in Romanian imaging specialists Hiperdia.
Brazil's third largest lab group Alliar floated on Friday 28 October at R$20 per share. This raises roughly US$88m in cash for its buy-and-build in southern Brazil. Investors celebrate the accomplishment as it puts an end to a yearlong IPO drought in Sao Paulo amidst recession.
Pan-European testing network Eurofins has failed to raise debt according to several sources. It is widely understood that the group wants to conduct a large acquisition soon.
UK care provider Cambian has hired banker Rothschild to sell off its adult care division – the most profitable and the one with the highest occupancy rates. The sale should cover Cambian's refinancing needs following two profit warnings and a breach in its debt covenants during the past year.
Summit Capital is selling UK veterinary group Independent Vetcare (IVC), a source said. Potential bidders are Nordic private equity houses EQT and Nordic Capital. They each run a pan-European veterinary operation, Anicura and Evidensia, respectively.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
